VIENNA—Obesity and insulin resistance were named as important targets for primary prevention of breast cancer by Pamela J. Goodwin, MD, MSc, FRCPC, Professor of Medicine and Director of the Marvelle K
VIENNA—Obesity and insulin resistance were named as important targets for primary prevention of breast cancer by Pamela J. Goodwin, MD, MSc, FRCPC, Professor of Medicine and Director of the Marvelle Koffler Breast Centre at the University of Toronto/Mount Sinai Hospital, Canada. Oncology Times reporter Sarah Maxwell asked her about the findings and recommendations to cancer doctors emerging from her long term investigations of these factors.